| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Regulation by p38 MAPK: Involvement of NF-
B with Implications for Therapy in Rheumatoid Arthritis1
Kennedy Institute of Rheumatology Division, Imperial College School of Medicine Hammersmith, London, United Kingdom
TNF-
is a key factor in a variety of inflammatory diseases. This study examines the role of p38 MAPK in the regulation of TNF- in primary human cells relevant to inflammation, e.g., macrophages and rheumatoid synovial cells. Using a dominant negative variant (D168A) of p38 MAPK and a kinase inhibitor, SB203580, we confirm in primary human macrophages that p38 MAPK regulates TNF- production using a posttranscriptional mechanism requiring the 3' untranslated region of the gene. However, in LPS-activated primary human macrophages we also detect a second previously unidentified mechanism, the p38 MAPK modulation of TNF- transcription. This is mediated through p38 MAPK regulation of NF-
B. Interestingly this mechanism was not observed in rheumatoid synovial cells. Importantly however, the dominant negative mutant of p38 MAPK, but not SB203580 was effective at inhibiting spontaneous TNF- production in these ex vivo rheumatoid synovial cell cultures. These data indicate there are potential major differences in the role of p38 MAPK in inflammatory signaling that have a bearing on the use of this kinase as a target for therapy. These results indicate despite disappointing results with p38 MAPK inhibitors in the clinic, this kinase is a valid target in rheumatoid disease.
This article has been cited by other articles:
|
|
 |
|
  R. J. Hill, K. Dabbagh, D. Phippard, C. Li, R. T. Suttmann, M. Welch, E. Papp, K. W. Song, K.-c. Chang, D. Leaffer, et al. Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 610 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Haase, J. L. Ober-Blobaum, G. Engelhardt, S. Hebel, A. Heit, H. Heine, and L. Rink Zinc Signals Are Essential for Lipopolysaccharide-Induced Signal Transduction in Monocytes J. Immunol., November 1, 2008; 181(9): 6491 - 6502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shiraishi, H. Yoshida, K. Saeki, Y. Miura, S. Watanabe, T. Ishizaki, M. Hashimoto, G. Takaesu, T. Kobayashi, and A. Yoshimura Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells Int. Immunol., September 1, 2008; 20(9): 1219 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dagvadorj, Y. Naiki, G. Tumurkhuu, F. Hassan, S. Islam, N. Koide, I. Mori, T. Yoshida, and T. Yokochi Interleukin-10 inhibits tumor necrosis factor-{alpha} production in lipopolysaccharide-stimulated RAW 264.7 cells through reduced MyD88 expression Innate Immunity, April 1, 2008; 14(2): 109 - 115. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Thalhamer, M. A. McGrath, and M. M. Harnett MAPKs and their relevance to arthritis and inflammation Rheumatology, April 1, 2008; 47(4): 409 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Palmer, B. E. Mutch, S. Workman, J. P. McDaid, N. J. Horwood, and B. M. J. Foxwell Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NF{kappa}B activity Blood, February 15, 2008; 111(4): 1781 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Partridge, H. Carlsen, K. Enesa, H. Chaudhury, M. Zakkar, L. Luong, A. Kinderlerer, M. Johns, R. Blomhoff, J. C. Mason, et al. Laminar shear stress acts as a switch to regulate divergent functions of NF-{kappa}B in endothelial cells FASEB J, November 1, 2007; 21(13): 3553 - 3561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M Sacre, S. K Drexler, E. Andreakos, M. Feldmann, F. M Brennan, and B. M J Foxwell Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii81 - iii86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Li, Y. Laumonnier, T. Syrovets, and T. Simmet Plasmin Triggers Cytokine Induction in Human Monocyte-Derived Macrophages Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1383 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Leiba, L. Cahalon, A. Shimoni, O. Lider, A. Zanin-Zhorov, I. Hecht, U. Sela, I. Vlodavsky, and A. Nagler Halofuginone inhibits NF-{kappa}B and p38 MAPK in activated T cells J. Leukoc. Biol., August 1, 2006; 80(2): 399 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Qasimi, A. Ming-Lum, A. Ghanipour, C. J. Ong, M. E. Cox, J. Ihle, N. Cacalano, A. Yoshimura, and A. L-F. Mui Divergent Mechanisms Utilized by SOCS3 to Mediate Interleukin-10 Inhibition of Tumor Necrosis Factor {alpha} and Nitric Oxide Production by Macrophages J. Biol. Chem., March 10, 2006; 281(10): 6316 - 6324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Birrell, S. Wong, K. McCluskie, M. C. Catley, E. L. Hardaker, S. Haj-Yahia, and M. G. Belvisi Second-Generation Inhibitors Demonstrate the Involvement of p38 Mitogen-Activated Protein Kinase in Post-Transcriptional Modulation of Inflammatory Mediator Production in Human and Rodent Airways J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1318 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Johansen, A. T. Funding, K. Otkjaer, K. Kragballe, U. B. Jensen, M. Madsen, L. Binderup, T. Skak-Nielsen, M. S. Fjording, and L. Iversen Protein Expression of TNF-{alpha} in Psoriatic Skin Is Regulated at a Posttranscriptional Level by MAPK-Activated Protein Kinase 2 J. Immunol., February 1, 2006; 176(3): 1431 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhou, F. Li, L. Kong, H. Tomita, C. Li, and W. Cao Involvement of Inflammation, Degradation, and Apoptosis in a Mouse Model of Glaucoma J. Biol. Chem., September 2, 2005; 280(35): 31240 - 31248. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
